Anthony J. Cannon, MD, FACE

4.87 out of 5 (385 ratings, 134 reviews)
Ratings and Reviews

Departments

Cooper University Health Care Titles

  • Endocrinologist

Cooper Medical School of Rowan University Titles

  • Clinical Associate Professor of Medicine

Board Certifications

  • American Board of Internal Medicine (Internal Medicine)
  • American Board of Internal Medicine (Endocrinology, Diabetes, and Metabolism)

Professional Type

Cooper Care Alliance

NPI

1831259340

Office Locations

Cherry Hill
Cooper Care Alliance at Brace Road

1210 Brace Road
Cherry Hill , NJ 08034
Phone: 856.536.1515
Maps & Directions

Education & Training

Medical SchoolCornell University, New York, NY
InternshipInternal Medicine - Hartford Hospital, Hartford, CT
ResidencyInternal Medicine - Baystate Medical Center, Springfield, MA
FellowshipEndocrinology, Temple University Hospital, Philadelphia, PA

Memberships

  • American Diabetes Association
  • National Medical Association
  • Thyroid Club of South Jersey
  • American Association of Clinical Endocrinologists (AACE)

Awards and Honors

  • Recipient, American Diabetes Association Chair’s Citation Award - 2015
  • Fellow, American College of Endocrinology, FACE - 2012

Publications

Cannon A, Handelsman Y, Heile M, Shannon M. Burden of Illness in Type 2 Diabetes Mellitus. J Manag Care Spec Pharm. 2018 Sep;24(9-a Suppl):S5-S13. doi: 10.18553/jmcp.2018.24.9-a.s5. PMID: 30156443.

Handelsman Y, Wyne K, Cannon A, Shannon M, Schneider D. Glycemic Efficacy, Weight Effects, and Safety of Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists. J Manag Care Spec Pharm. 2018 Sep;24(9-a Suppl):S14-S29. doi: 10.18553/jmcp.2018.24.9-a.s14. Erratum in: J Manag Care Spec Pharm. 2018 Nov;24(11):1196a. PMID: 30156445.

Heile M, Wyne K, Billings LK, Cannon A, Handelsman Y, Shannon M. Cardiovascular Outcomes with Once-Weekly GLP-1 RAs: Clinical and Economic Implications. J Manag Care Spec Pharm. 2018 Sep;24(9-a Suppl):S42-S52. doi: 10.18553/jmcp.2018.24.9-a.s42. PMID: 30156446.

Cannon A, Handelsman Y, Heile M, Shannon M. Burden of Illness in Type 2 Diabetes Mellitus. J Manag Care Spec Pharm. 2018 Sep;24(9-a Suppl):S5-S13. doi: 10.18553/jmcp.2018.24.9-a.s5. PMID: 30156443.

Shomali ME, Ørsted DD, Cannon AJ. Efficacy and safety of liraglutide, a once-daily human glucagon-like peptide-1 receptor agonist, in African-American people with Type 2 diabetes: a meta-analysis of sub-population data from seven phase III trials. Diabet Med. 2017 Feb;34(2):197-203. doi: 10.1111/dme.13185. Epub 2016 Aug 16. PMID: 27412701; PMCID: PMC5248619.

Ard J, Cannon A, Lewis CE, Lofton H, Vang Skjøth T, Stevenin B, Pi-Sunyer X. Efficacy and safety of liraglutide 3.0 mg for weight management are similar across races: subgroup analysis across the SCALE and phase II randomized trials. Diabetes Obes Metab. 2016 Apr;18(4):430-5. doi: 10.1111/dom.12632. Epub 2016 Feb 11. PMID: 26744025; PMCID: PMC6084344.

Peyrot M, Egede LE, Campos C, Cannon AJ, Funnell MM, Hsu WC, Ruggiero L, Siminerio LM, Stuckey HL. Ethnic differences in psychological outcomes among people with diabetes: USA results from the second Diabetes Attitudes, Wishes, and Needs (DAWN2) study. Curr Med Res Opin. 2014 Nov;30(11):2241-54. doi: 10.1185/03007995.2014.947023. Epub 2014 Aug 18. PMID: 25079662.

Mehta JM, Miller JL, Cannon AJ, Mardekian SK, Kenyon LC, Jabbour SA. Ovarian leydig cell hyperplasia: an unusual case of virilization in a postmenopausal woman. Case Rep Endocrinol. 2014;2014:762745. doi: 10.1155/2014/762745. Epub 2014 Jun 19. PMID: 25045549; PMCID: PMC4089940.

Cannon AJ. Delivering culturally competent care in clinical practice: a call to action. J Natl Med Assoc. 2012 Jan-Feb;104(1-2):104-7. doi: 10.1016/s0027-9684(15)33514-8. PMID: 22708254.

Ratings and Reviews

Ratings and reviews come from patient responses to health care provider-related questions on the Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CG-CAHPS) Patient Experience Survey that Cooper sends to patients after outpatient office visits.  Learn more about our survey and how ratings are calculated >>

Overall Rating

4.87 out of 5 (385 ratings, 134 reviews)
Nov 12, 2023
Dr. Cannon is a very good endocrinologist. He takes time to explain every little detail to you.
Nov 12, 2023
Dr.Cannon and his staff are very professional, knowledgeable, caring, informative and helpful.
Nov 12, 2023
Dr. Cannon was wonderful
Oct 12, 2023
Dr. Cannon is the best! !
Oct 12, 2023
Alway have great visits learn a lot about my health
Oct 12, 2023
ALL GOOD Dr. Cannon is THE BEST
Oct 12, 2023
Wonderful experience always
Oct 12, 2023
My visit with Dr. Cannon and his assistant were exceptional. He has always been courteous and sensitive to my concerns.
Oct 12, 2023
Dr. Cannon is an extremely well informed doctor, and knows how to speak to a person in understandable language. I think he is the best Endocrinologist I have ever seen, and I enjoy my visits with him.
Oct 12, 2023
I have been seeing Dr. Cannon for 9 years. Like the treatment he provides very much which is why I travel an hour to my appointments.